ZXX-26752-49802

Timeline

1. 2021-03-23
   Dose 1 — Pfizer-BioNTech
2. 2021-03-24
   Registered in v-safe
3. 2021-03-24
   Survey response — days 1–6 daily, dose 1

   MedDRA: Dysgeusia, Immediate post-injection reaction — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

   Free text: metallic taste in mouth, began 15 min after injection

   MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
4. 2021-03-25
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · None

   Adult check-in
5. 2021-03-26
   Health check-in — days 1–6 daily, dose 1

   Feeling: Fair · Headache

   Adult check-in
6. 2021-03-27
   Health check-in — days 1–6 daily, dose 1

   Feeling: Good · Fatigue or tiredness

   Adult check-in
7. 2021-04-14
   Dose 2 — Pfizer-BioNTech
8. 2021-04-15
   Health check-in — days 1–6 daily, dose 2

   Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work

   Adult check-in
9. 2021-04-16
   Health check-in — days 1–6 daily, dose 2

   Feeling: Fair · Site: Pain · Fatigue or tiredness

   Adult check-in
10. 2021-04-18
    Health check-in — days 1–6 daily, dose 2

    Feeling: Good · None

    Adult check-in
11. 2021-04-21
    Health check-in — day 7, dose 2

    Feeling: Fair · Joint pains

    Adult check-in
12. 2021-10-13
    Health check-in — 6 months, dose 2

    Feeling: Good

    Adult check-in
13. 2021-12-01
    Dose 3 — Pfizer-BioNTech
14. 2021-12-01
    Survey response — day 0, dose 3

    MedDRA: Dysgeusia — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness · Be unable to work or attend school

    Free text: Metallic taste in mouth

    MedDRA releases: 2024-11 · check-in free text available
15. 2021-12-02
    Health check-in — days 1–6 daily, dose 3

    Feeling: Poor · Site: Itching · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities

    Adult check-in
16. 2021-12-04
    Health check-in — days 1–6 daily, dose 3

    Feeling: Good · None

    Adult check-in
17. 2021-12-08
    Health check-in — day 7, dose 3

    Feeling: Good · None

    Adult check-in
18. 2022-01-05
    Health check-in — day 35, dose 3

    Feeling: Good

    Adult check-in
19. 2022-01-12
    Survey response — day 42, dose 3

    MedDRA: COVID-19, Cough, Dyspnoea, Fatigue, Headache, Oropharyngeal pain, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

    Free text: Came down with covid sometime last week, tested positive Monday. Symptoms include difficulty breathing, moderate headache unhelped by meds, cough, moderate to severe fatigue, frequently becoming winded, sore throat.

    MedDRA releases: 2024-11 · check-in free text available
20. 2022-06-01
    Survey response — 6 months, dose 3

    MedDRA: Pneumonia, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

    Free text: Diagnosed with pneumonia two weeks ago after an URI went south.

    MedDRA releases: 2024-11 · check-in free text available
21. 2022-06-01
    Report sent to call center — 6 months, dose 3

    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

    Outpatient clinic or urgent care clinic visit · 1 call case(s)
22. 2022-06-02
    Call 1 — Left Voicemail